{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:46:17Z","timestamp":1781700377977,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T00:00:00Z","timestamp":1593820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T00:00:00Z","timestamp":1593820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s10096-020-03955-z","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T10:03:43Z","timestamp":1594202623000},"page":"2121-2131","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Complement levels in patients with bloodstream infection due to Staphylococcus aureus or Gram-negative bacteria"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2469-0638","authenticated-orcid":false,"given":"Emily M.","family":"Eichenberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Dagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Ruffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumathi","family":"Sivapalasingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Vance G.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brinda C.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,4]]},"reference":[{"key":"3955_CR1","doi-asserted-by":"crossref","unstructured":"Pliakos EE, Andreatos N, Shehadeh F, Ziakas PD, Mylonakis E (2018) The cost-effectiveness of rapid diagnostic testing for the diagnosis of bloodstream infections with or without antimicrobial stewardship. Clin Microbiol Rev 31(3):e00095\u201317","DOI":"10.1128\/CMR.00095-17"},{"key":"3955_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/1469-0691.12195","volume":"19","author":"M Goto","year":"2013","unstructured":"Goto M, Al-Hasan MN (2013) Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect 19:501\u2013509","journal-title":"Clin Microbiol Infect"},{"key":"3955_CR3","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1128\/CMR.05022-11","volume":"25","author":"SJ van Hal","year":"2012","unstructured":"van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB (2012) Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev 25:362\u2013386","journal-title":"Clin Microbiol Rev"},{"key":"3955_CR4","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1086\/605555","volume":"49","author":"H Ammerlaan","year":"2009","unstructured":"Ammerlaan H, Seifert H, Harbarth S, Brun-Buisson C, Torres A, Antonelli M, Kluytmans J, Bonten M (2009) Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries. Clin Infect Dis 49:997\u20131005","journal-title":"Clin Infect Dis"},{"key":"3955_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/iju.13451","volume":"25","author":"AL Ackerman","year":"2018","unstructured":"Ackerman AL, Parameshwar PS, Anger JT (2018) Diagnosis and treatment of patients with prostatic abscess in the post-antibiotic era. Int J Urol 25:103\u2013110","journal-title":"Int J Urol"},{"key":"3955_CR6","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.1096\/fj.08-110595","volume":"22","author":"MA Flierl","year":"2008","unstructured":"Flierl MA, Rittirsch D, Nadeau BA, Day DE, Zetoune FS, Sarma JV, Huber-Lang MS, Ward PA (2008) Functions of the complement components C3 and C5 during sepsis. FASEB J 22:3483\u20133490","journal-title":"FASEB J"},{"key":"3955_CR7","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1111\/j.1582-4934.2009.00893.x","volume":"13","author":"PA Ward","year":"2009","unstructured":"Ward PA, Gao H (2009) Sepsis, complement and the dysregulated inflammatory response. J Cell Mol Med 13:4154\u20134160","journal-title":"J Cell Mol Med"},{"key":"3955_CR8","doi-asserted-by":"publisher","first-page":"407324","DOI":"10.1155\/2012\/407324","volume":"2012","author":"J Charchaflieh","year":"2012","unstructured":"Charchaflieh J, Wei J, Labaze G, Hou YJ, Babarsh B, Stutz H, Lee H, Worah S, Zhang M (2012) The role of complement system in septic shock. Clin Dev Immunol 2012:407324","journal-title":"Clin Dev Immunol"},{"key":"3955_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00281-017-0639-8","volume":"39","author":"BG Chousterman","year":"2017","unstructured":"Chousterman BG, Swirski FK, Weber GF (2017) Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol 39:517\u2013528","journal-title":"Semin Immunopathol"},{"key":"3955_CR10","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/00003246-199206000-00025","volume":"20","author":"Anonymous","year":"1992","unstructured":"Anonymous (1992) American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864\u2013874","journal-title":"Crit Care Med"},{"key":"3955_CR11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc11454","volume":"17","author":"JA Kellum","year":"2013","unstructured":"Kellum JA, Lameire N (2013) Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 17:204","journal-title":"Crit Care"},{"key":"3955_CR12","doi-asserted-by":"publisher","unstructured":"Souli M, Ruffin F, Choi SH, Park LP, Gao S, Lent NC, Sharma-Kuinkel BK, Thaden JT, Maskarinec SA, Wanda L, Hill-Rorie J, Warren B, Hansen B, Fowler VG (2019) Changing characteristics of Staphylococcus aureus bacteremia: results from a 21-year, prospective, Longitudinal Study. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciz112","DOI":"10.1093\/cid\/ciz112"},{"key":"3955_CR13","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/0002-9610(73)90169-4","volume":"125","author":"JA Harris","year":"1973","unstructured":"Harris JA, Cobbs CG (1973) Persistent gram-negative bacteremia. Observations in twenty patients. Am J Surg 125:705\u2013717","journal-title":"Am J Surg"},{"key":"3955_CR14","volume-title":"Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline\u2014third edition","author":"CLSI","year":"2010","unstructured":"CLSI (2010) Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline\u2014third edition. Clinical Lab Standards Institute, Wayne"},{"key":"3955_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.hoc.2015.02.001","volume":"29","author":"JC Varela","year":"2015","unstructured":"Varela JC, Tomlinson S (2015) Complement: an overview for the clinician. Hematol Oncol Clin North Am 29:409\u2013427","journal-title":"Hematol Oncol Clin North Am"},{"key":"3955_CR16","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/cmi.2017.68","volume":"14","author":"R Xu","year":"2017","unstructured":"Xu R, Lin F, Bao C, Wang FS (2017) Mechanism of C5a-induced immunologic derangement in sepsis. Cell Mol Immunol 14:792\u2013793","journal-title":"Cell Mol Immunol"},{"key":"3955_CR17","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.4049\/jimmunol.166.2.1193","volume":"166","author":"M Huber-Lang","year":"2001","unstructured":"Huber-Lang M, Sarma VJ, Lu KT, McGuire SR, Padgaonkar VA, Guo RF, Younkin EM, Kunkel RG, Ding J, Erickson R, Curnutte JT, Ward PA (2001) Role of C5a in multiorgan failure during sepsis. J Immunol 166:1193\u20131199","journal-title":"J Immunol"},{"key":"3955_CR18","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/0002-9343(89)90224-6","volume":"86","author":"CE Hack","year":"1989","unstructured":"Hack CE, Nuijens JH, Felt-Bersma RJ, Schreuder WO, Eerenberg-Belmer AJ, Paardekooper J, Bronsveld W, Thijs LG (1989) Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. Am J Med 86:20\u201326","journal-title":"Am J Med"},{"key":"3955_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S1521-6616(02)00025-6","volume":"106","author":"AB Groeneveld","year":"2003","unstructured":"Groeneveld AB, Tacx AN, Bossink AW, van Mierlo GJ, Hack CE (2003) Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection. Clin Immunol 106:106\u2013115","journal-title":"Clin Immunol"},{"key":"3955_CR20","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1146\/annurev.immunol.23.021704.115835","volume":"23","author":"RF Guo","year":"2005","unstructured":"Guo RF, Ward PA (2005) Role of C5a in inflammatory responses. Annu Rev Immunol 23:821\u2013852","journal-title":"Annu Rev Immunol"},{"key":"3955_CR21","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1111\/j.1462-5822.2006.00709.x","volume":"8","author":"SH Rooijakkers","year":"2006","unstructured":"Rooijakkers SH, Ruyken M, van Roon J, van Kessel KP, van Strijp JA, van Wamel WJ (2006) Early expression of SCIN and CHIPS drives instant immune evasion by Staphylococcus aureus. Cell Microbiol 8:1282\u20131293","journal-title":"Cell Microbiol"},{"key":"3955_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nri1269","volume":"4","author":"PA Ward","year":"2004","unstructured":"Ward PA (2004) The dark side of C5a in sepsis. Nat Rev Immunol 4:133\u2013142","journal-title":"Nat Rev Immunol"},{"key":"3955_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000247157","volume":"2","author":"M von Kockritz-Blickwede","year":"2010","unstructured":"von Kockritz-Blickwede M, Konrad S, Foster S, Gessner JE, Medina E (2010) Protective role of complement C5a in an experimental model of Staphylococcus aureus bacteremia. J Innate Immun 2:87\u201392","journal-title":"J Innate Immun"},{"key":"3955_CR24","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.4049\/jimmunol.1500966","volume":"195","author":"M Georgoutsou-Spyridonos","year":"2015","unstructured":"Georgoutsou-Spyridonos M, Ricklin D, Pratsinis H, Perivolioti E, Pirmettis I, Garcia BL, Geisbrecht BV, Foukas PG, Lambris JD, Mastellos DC, Sfyroera G (2015) Attenuation of Staphylococcus aureus-induced bacteremia by human mini-antibodies targeting the complement inhibitory protein Efb. J Immunol 195:3946\u20133958","journal-title":"J Immunol"},{"key":"3955_CR25","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/10512","volume":"5","author":"BJ Czermak","year":"1999","unstructured":"Czermak BJ, Sarma V, Pierson CL, Warner RL, Huber-Lang M, Bless NM, Schmal H, Friedl HP, Ward PA (1999) Protective effects of C5a blockade in sepsis. Nat Med 5:788\u2013792","journal-title":"Nat Med"},{"key":"3955_CR26","doi-asserted-by":"publisher","first-page":"e47095","DOI":"10.1371\/journal.pone.0047095","volume":"7","author":"J Ren","year":"2012","unstructured":"Ren J, Zhao Y, Yuan Y, Han G, Li W, Huang Q, Tong Z, Li J (2012) Complement depletion deteriorates clinical outcomes of severe abdominal sepsis: a conspirator of infection and coagulopathy in crime? PLoS One 7:e47095","journal-title":"PLoS One"},{"key":"3955_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1553-2712.2010.00713.x","volume":"17","author":"JG Younger","year":"2010","unstructured":"Younger JG, Bracho DO, Chung-Esaki HM, Lee M, Rana GK, Sen A, Jones AE (2010) Complement activation in emergency department patients with severe sepsis. Acad Emerg Med 17:353\u2013359","journal-title":"Acad Emerg Med"},{"key":"3955_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4103\/0255-0857.129793","volume":"32","author":"S Modi","year":"2014","unstructured":"Modi S, Rashid M, Malik A, Shahid M (2014) Study of complement activation, C3 and interleukin-6 levels in burn patients and their role as prognostic markers. Indian J Med Microbiol 32:137\u2013142","journal-title":"Indian J Med Microbiol"},{"key":"3955_CR29","doi-asserted-by":"crossref","first-page":"976","DOI":"10.4049\/jimmunol.159.2.976","volume":"159","author":"MB Fischer","year":"1997","unstructured":"Fischer MB, Prodeus AP, Nicholson-Weller A, Ma M, Murrow J, Reid RR, Warren HB, Lage AL, Moore FD Jr, Rosen FS, Carroll MC (1997) Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement. J Immunol 159:976\u2013982","journal-title":"J Immunol"},{"key":"3955_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1203\/00006450-199404000-00002","volume":"35","author":"HA Lassiter","year":"1994","unstructured":"Lassiter HA, Wilson JL, Feldhoff RC, Hoffpauir JM, Klueber KM (1994) Supplemental complement component C9 enhances the capacity of neonatal serum to kill multiple isolates of pathogenic Escherichia coli. Pediatr Res 35:389\u2013396","journal-title":"Pediatr Res"},{"key":"3955_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1128\/IAI.18.1.14-22.1977","volume":"18","author":"JD Coonrod","year":"1977","unstructured":"Coonrod JD, Rylko-Bauer B (1977) Complement levels in pneumococcal pneumonia. Infect Immun 18:14\u201322","journal-title":"Infect Immun"},{"key":"3955_CR32","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.3389\/fimmu.2018.02664","volume":"9","author":"M Gaya da Costa","year":"2018","unstructured":"Gaya da Costa M, Poppelaars F, van Kooten C, Mollnes TE, Tedesco F, W\u00fcrzner R, Trouw LA, Truedsson L, Daha MR, Roos A, Seelen MA (2018) Age and sex-associated changes of complement activity and complement levels in a healthy Caucasian population. Front Immunol 9:2664","journal-title":"Front Immunol"},{"key":"3955_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.semnephrol.2013.08.005","volume":"33","author":"JW McCullough","year":"2013","unstructured":"McCullough JW, Renner B, Thurman JM (2013) The role of the complement system in acute kidney injury. Semin Nephrol 33:543\u2013556","journal-title":"Semin Nephrol"},{"key":"3955_CR34","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1017\/S0265021505000931","volume":"22","author":"T Schuerholz","year":"2005","unstructured":"Schuerholz T, Leuwer M, Cobas-Meyer M, Vangerow B, Kube F, Kirschfink M, Marx G (2005) Terminal complement complex in septic shock with capillary leakage: marker of complement activation? Eur J Anaesthesiol 22:541\u2013547","journal-title":"Eur J Anaesthesiol"},{"key":"3955_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/infdis\/jir276","volume":"204","author":"V Frodermann","year":"2011","unstructured":"Frodermann V, Chau TA, Sayedyahossein S, Toth JM, Heinrichs DE, Madrenas J (2011) A modulatory interleukin-10 response to staphylococcal peptidoglycan prevents Th1\/Th17 adaptive immunity to Staphylococcus aureus. J Infect Dis 204:253\u2013262","journal-title":"J Infect Dis"},{"key":"3955_CR36","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1093\/infdis\/jis552","volume":"206","author":"WE Rose","year":"2012","unstructured":"Rose WE, Eickhoff JC, Shukla SK, Pantrangi M, Rooijakkers S, Cosgrove SE, Nizet V, Sakoulas G (2012) Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremia. J Infect Dis 206:1604\u20131611","journal-title":"J Infect Dis"},{"key":"3955_CR37","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nm.1965","volume":"15","author":"TA Chau","year":"2009","unstructured":"Chau TA, McCully ML, Brintnell W, An G, Kasper KJ, Vines ED, Kubes P, Haeryfar SM, McCormick JK, Cairns E, Heinrichs DE, Madrenas J (2009) Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome. Nat Med 15:641\u2013648","journal-title":"Nat Med"},{"key":"3955_CR38","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448\u2013454","journal-title":"N Engl J Med"},{"key":"3955_CR39","first-page":"21","volume":"25","author":"EA Daef","year":"2018","unstructured":"Daef EA, Elsherbiny NM, Agban MN, Riad KF, Mohammed LF (2018) Bloodstream infections in febrile neutropenic pediatric Cancer patients: microbiological and sepsis biomarkers insight. Egypt J Immunol 25:21\u201334","journal-title":"Egypt J Immunol"},{"key":"3955_CR40","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1097\/TP.0000000000000434","volume":"98","author":"KG Miedema","year":"2014","unstructured":"Miedema KG, Vermont CL, Ball LM, de Bont ES, Kamps WA, van Tol MJ, Jol-van der Zijde CM, Tissing WJ (2014) The diagnostic value of interleukin-8 for the detection of bacteremia in pediatric hematopoietic stem cell recipients with febrile neutropenia. Transplantation 98:e80\u2013e81","journal-title":"Transplantation"},{"key":"3955_CR41","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/0090-1229(92)90036-N","volume":"62","author":"CE Spooner","year":"1992","unstructured":"Spooner CE, Markowitz NP, Saravolatz LD (1992) The role of tumor necrosis factor in sepsis. Clin Immunol Immunopathol 62:S11\u2013S17","journal-title":"Clin Immunol Immunopathol"},{"key":"3955_CR42","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/CJN.08570814","volume":"11","author":"AC Wiseman","year":"2016","unstructured":"Wiseman AC (2016) Immunosuppressive medications. Clin J Am Soc Nephrol 11:332\u2013343","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-03955-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-020-03955-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-020-03955-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T17:29:30Z","timestamp":1696354170000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-020-03955-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,4]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["3955"],"URL":"https:\/\/doi.org\/10.1007\/s10096-020-03955-z","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,4]]},"assertion":[{"value":"10 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Vance Fowler reports personal fees from Novartis, Novadigm, Durata, Debiopharm, Genentech, Achaogen, Affinium, Medicines Co., Cerexa, Tetraphase, Trius, MedImmune, Bayer, Theravance, Basilea, Affinergy, Janssen, xBiotech, Contrafect, Regeneron, Basilea, Destiny, and Amphliphi Biosciences. Integrated Biotherapeutics; C3J, grants from NIH, MedImmune, Cerexa\/Forest\/Actavis\/Allergan, Pfizer, Advanced Liquid Logics, Theravance, Novartis, and Cubist\/Merck; Medical Biosurfaces; Locus; Affinergy; Contrafect; Karius; Genentech, Regeneron, Basilea, and Janssen, from Green Cross, Cubist, Cerexa, Durata, Theravance; Debiopharm, Royalties from UpToDate; and a patent sepsis diagnostics pending.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the Duke Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all participants or their legally authorized representatives prior to their enrollment in this study","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}